Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Cell Counting Market Poised To Hit $17.83 Billion By 2030 With A 9.3% CAGR
The cell counting market has experienced significant expansion in recent years. Its valuation is expected to rise from $11.39 billion in 2025 to $12.49 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 9.7%. This growth witnessed in the past can be ascribed to the broadening of life sciences research activities, an increasing reliance on cell culture techniques, greater investments in pharmaceutical research, enhanced academic research funding, and the widespread integration of laboratory automation.
The cell counting market size is expected to witness substantial growth in the upcoming years. It is forecast to reach $17.83 billion in 2030, growing at a compound annual growth rate (CAGR) of 9.3%. This anticipated expansion over the forecast period is attributed to the increasing demand for cell-based therapies, the rising adoption of precision diagnostics, the expansion of biotechnology research pipelines, the growing utilization of AI-enabled laboratory analytics, and an increasing focus on standardized laboratory workflows. Key trends during this period include the rising adoption of automated cell counting systems, an increase in the use of flow cytometry-based cell analysis, growing demand for high-throughput cell counting, the expansion of cell-based research applications, and an enhanced focus on data accuracy and reproducibility.
Get A Free Sample Report With In-Depth Market Insights:
Cell Counting Market Demand Drivers Opening New Revenue Streams
The increasing incidence of chronic diseases is anticipated to drive the expansion of the cell counting market in the forthcoming years. Chronic diseases are characterized as conditions lasting a year or more, requiring continuous medical care, impeding daily activities, or both. These ailments often feature complex etiologies, multiple risk factors, lengthy incubation periods, extended illness, and result in reduced function or impairment. Cell counting provides an essential diagnostic, monitoring, and therapeutic approach for chronic illnesses. It aids healthcare professionals in identifying and tracking shifts in cell counts, which can provide critical data concerning disease advancement and treatment efficacy. For instance, in June 2024, according to the National Health Service, a UK-based government department, 3,615,330 individuals registered with a general practitioner (GP) were diagnosed with non-diabetic hyperglycemia or pre-diabetes (a condition with elevated blood sugar levels, not high enough to be classified as diabetes) in 2023, representing an 18% increase from 3,065,825 cases in 2022. Hence, the growing prevalence of chronic diseases is propelling the cell counting market.
Cell Counting Market Segments: Where Is Growth Concentrated?
The cell counting market covered in this report is segmented –
1) By Consumables And Accessories: Media, Sera And Reagents, Assay Kits, Microplates
2) By Product: Multi-Mode Readers, Cell Counters, Automated Cell Counters, Hemocytometers, Manual Cell Counters, Flow Cytometers
3) By Application: Research Applications, Clinical And Diagnostic Applications, Industrial Applications
4) By End-User: Hospitals And Diagnostic, Research Institutions, Pharmaceutical And Biotechnology Companies, Other End-Users
Subsegments:
1) By Media: Cell Culture Media, Specialized Growth Media
2) By Sera and Reagents: Fetal Bovine Serum (FBS), Human Serum, Reagents for Cell Viability
3) By Assay Kits: Cell Counting Kits, Apoptosis Detection Kits
4) By Microplates: 96-Well Plates, 384-Well Plates, Specialized Cell Culture Plates
Cell Counting Market Trends Powering Strategic Industry Growth
Leading companies in the cell counting market are concentrating on innovative products such as the BD FACSDiscover S8 spectral cell sorter to better satisfy the requirements of their existing clientele. Spectral cell sorting represents a revolutionary method that categorizes cells based on their visual attributes by merging advanced spectral flow cytometry with high-speed imaging technologies. Unlike traditional flow cytometry, which identifies specific fluorescent bands, spectral flow cytometry gathers the entire spectrum of signals generated by sample arrangements, facilitating multi-parameter sorting. For example, in May 2023, Becton, Dickinson, and Company, a US-based firm producing medical devices, instrument systems, and reagents, launched the BD FACSDiscover S8 Cell Sorter. This device introduces two transformative technologies that enable researchers to uncover previously undetectable information about cells during standard flow cytometry investigations. With BD CellView Image Technology, researchers can examine comprehensive microscopic images of individual cells and sort them rapidly based on visual criteria to validate findings in real time. Furthermore, BD SpectralFX Technology allows researchers to conduct high-parameter studies using full-spectrum cell sorting and experience enhanced performance, thanks to a new flexible optical architecture and system-aware algorithms. The integration of these advancements within the BD FACSDiscover S8 Cell Sorter broadens the capabilities of researchers, holding the potential to revolutionize research and cell-based therapy development in various areas, including drug discovery, immuno-oncology, and genomics.
Cell Counting Market Key Participants And Competitive Landscape
Major companies operating in the cell counting market are Thermo Fisher Scientific Inc., Merck KGaA, PerkinElmer Inc., Bio-Rad Laboratories Inc., Danaher Corporation, Olympus Corporation, HORIBA Ltd., Logos Biosystems Inc., Becton Dickinson and Company, GE Healthcare, Agilent Technologies Inc., BioTek Instruments Inc., DeNovix Inc., Sysmex Corporation, Nexcelom Bioscience LLC, Beckman Coulter Inc., Roche Diagnostics International Ltd., Miltenyi Biotec GmbH, AccuBioTech Co. Ltd., ChemoMetec A/S, Countstar Microscopy Systems, Luminex Corporation, NanoEnTek Inc., Partec GmbH, Advanced Instruments Inc., Analytik Jena AG, Integra Biosciences AG, Meridian Bioscience Inc., Promega Corporation, Sartorius AG
View The Full Cell Counting Market Report:
Cell Counting Market Geographic Analysis: Where Is Demand Rising Fastest?
North America was the largest region in the cell counting market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell counting market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
